Clinical Study With Ibrutinib and Venetoclax for Patients With Relapsed/Refractory Chronic Lymphocytic Leukemia
Clinical trial NCT04754035 · UNKNOWN
Trial details
- NCT number
- NCT04754035
- Sponsor
- Paolo Ghia
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-08
- Primary completion
- 2018-07-31
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.